TY - JOUR PY - 2012 DA - 2012// TI - KDIGO clinical practice guideline for anemia in chronic kidney disease JO - Kidney Int Suppl VL - 2 UR - https://doi.org/10.1038/kisup.2012.37 DO - 10.1038/kisup.2012.37 ID - ref1 ER - TY - STD TI - National Institute for Health and Care Excellence (NICE). Chronic kidney disease: managing anaemia. 2015 NICE guideline. https://www.nice.org.uk/guidance/ng8. Accessed 7 Sep 2018. UR - https://www.nice.org.uk/guidance/ng8 ID - ref2 ER - TY - JOUR AU - Tsukamoto, T. AU - Matsubara, T. AU - Akashi, Y. AU - Kondo, M. AU - Yanagita, M. PY - 2016 DA - 2016// TI - Annual iron loss associated with hemodialysis JO - Am J Nephrol VL - 43 UR - https://doi.org/10.1159/000444335 DO - 10.1159/000444335 ID - Tsukamoto2016 ER - TY - JOUR AU - Rostoker, G. AU - Vaziri, N. D. AU - Fishbane, S. PY - 2016 DA - 2016// TI - Iatrogenic iron overload in dialysis patients at the beginning of the 21st century JO - Drugs VL - 76 UR - https://doi.org/10.1007/s40265-016-0569-0 DO - 10.1007/s40265-016-0569-0 ID - Rostoker2016 ER - TY - JOUR AU - Biggar, P. AU - Leistikow, F. AU - Walper, A. PY - 2016 DA - 2016// TI - A prospective observational study of effectiveness and safety of iron isomaltoside in patients with chronic renal failure and iron deficiency anemia JO - Clin Nephrol VL - 86 UR - https://doi.org/10.5414/CN108941 DO - 10.5414/CN108941 ID - Biggar2016 ER - TY - JOUR AU - Mehdi, U. AU - Toto, R. D. PY - 2009 DA - 2009// TI - Anemia, diabetes, and chronic kidney disease JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc08-0779 DO - 10.2337/dc08-0779 ID - Mehdi2009 ER - TY - JOUR AU - Palmer, S. C. AU - Navaneethan, S. D. AU - Craig, J. C. AU - Johnson, D. W. AU - Tonelli, M. AU - Garg, A. X. PY - 2010 DA - 2010// TI - Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease JO - Ann Intern Med VL - 153 UR - https://doi.org/10.7326/0003-4819-153-1-201007060-00252 DO - 10.7326/0003-4819-153-1-201007060-00252 ID - Palmer2010 ER - TY - JOUR AU - Luporsi, E. AU - Mahi, L. AU - Morre, C. AU - Wernli, J. AU - Pouvourville, G. AU - Bugat, R. PY - 2012 DA - 2012// TI - Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective JO - J Med Econ VL - 15 UR - https://doi.org/10.3111/13696998.2011.639823 DO - 10.3111/13696998.2011.639823 ID - Luporsi2012 ER - TY - JOUR AU - Kalra, P. A. AU - Bhandari, S. PY - 2016 DA - 2016// TI - Safety of intravenous iron use in chronic kidney disease JO - Curr Opin Nephrol Hypertens VL - 25 UR - https://doi.org/10.1097/MNH.0000000000000263 DO - 10.1097/MNH.0000000000000263 ID - Kalra2016 ER - TY - JOUR AU - Zager, R. A. AU - Johnson, A. C. AU - Hanson, S. Y. AU - Wasse, H. PY - 2002 DA - 2002// TI - Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury JO - Am J Kidney Dis VL - 40 UR - https://doi.org/10.1053/ajkd.2002.33917 DO - 10.1053/ajkd.2002.33917 ID - Zager2002 ER - TY - JOUR AU - Zager, R. A. AU - Johnson, A. C. AU - Hanson, S. Y. PY - 2004 DA - 2004// TI - Parenteral iron nephrotoxicity: potential mechanisms and consequences JO - Kidney Int VL - 66 UR - https://doi.org/10.1111/j.1523-1755.2004.00716.x DO - 10.1111/j.1523-1755.2004.00716.x ID - Zager2004 ER - TY - JOUR AU - Jahn, M. R. AU - Andreasen, H. B. AU - Fütterer, S. AU - Nawroth, T. AU - Schünemann, V. AU - Kolb, U. PY - 2011 DA - 2011// TI - A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications JO - Eur J Pharm Biopharm VL - 78 UR - https://doi.org/10.1016/j.ejpb.2011.03.016 DO - 10.1016/j.ejpb.2011.03.016 ID - Jahn2011 ER - TY - JOUR AU - Kalra, P. A. AU - Bock, K. AU - Meldal, M. PY - 2012 DA - 2012// TI - Iron isomaltoside 1000: a new high dose option for parenteral iron therapy JO - Port J Nephrol Hypert VL - 26 ID - Kalra2012 ER - TY - JOUR AU - Bhandari, S. AU - Kalra, P. A. AU - Kothari, J. AU - Ambühl, P. M. AU - Christensen, J. H. AU - Essaian, A. M. PY - 2015 DA - 2015// TI - A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients JO - Nephrol Dial Transplant VL - 30 UR - https://doi.org/10.1093/ndt/gfv096 DO - 10.1093/ndt/gfv096 ID - Bhandari2015 ER - TY - JOUR AU - Schiesser, D. AU - Binet, I. AU - Tsinalis, D. AU - Dickenmann, M. AU - Keusch, G. AU - Schmidli, M. PY - 2006 DA - 2006// TI - Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients JO - Nephrol Dial Transplant VL - 21 UR - https://doi.org/10.1093/ndt/gfl419 DO - 10.1093/ndt/gfl419 ID - Schiesser2006 ER - TY - JOUR AU - Macdougall, I. C. PY - 2017 DA - 2017// TI - Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions JO - Clin Kidney J VL - 10 UR - https://doi.org/10.1093/ckj/sfx043 DO - 10.1093/ckj/sfx043 ID - Macdougall2017 ER - TY - JOUR AU - Fütterer, S. AU - Andrusenko, I. AU - Kolb, U. AU - Hofmeister, W. AU - Langguth, P. PY - 2013 DA - 2013// TI - Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD) JO - J Pharm Biomed Anal VL - 86 UR - https://doi.org/10.1016/j.jpba.2013.08.005 DO - 10.1016/j.jpba.2013.08.005 ID - Fütterer2013 ER - TY - STD TI - European Medicines Agency. The directive 2001/20/EC of the European Parliament and of the council article 2(c). Off J Eur Communities 2001;L121:34–44. ID - ref18 ER - TY - JOUR AU - Pisoni, R. L. AU - Fuller, D. S. AU - Bieber, B. A. AU - Gillespie, B. W. AU - Robinson, B. M. PY - 2012 DA - 2012// TI - The DOPPS practice monitor for US dialysis care: trends through august 2011 JO - Am J Kidney Dis VL - 60 UR - https://doi.org/10.1053/j.ajkd.2012.04.001 DO - 10.1053/j.ajkd.2012.04.001 ID - Pisoni2012 ER - TY - JOUR AU - Ferrari, P. AU - Kulkarni, H. AU - Dheda, S. AU - Betti, S. AU - Harrison, C. AU - St Pierre, T. G. PY - 2011 DA - 2011// TI - Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease JO - Clin J Am Soc Nephrol VL - 6 UR - https://doi.org/10.2215/CJN.04190510 DO - 10.2215/CJN.04190510 ID - Ferrari2011 ER - TY - JOUR AU - Ghoti, H. AU - Rachmilewitz, E. A. AU - Simon-Lopez, R. AU - Gaber, R. AU - Katzir, Z. AU - Konen, E. PY - 2012 DA - 2012// TI - Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron JO - Eur J Haematol VL - 89 UR - https://doi.org/10.1111/j.1600-0609.2012.01783.x DO - 10.1111/j.1600-0609.2012.01783.x ID - Ghoti2012 ER - TY - JOUR AU - Rostoker, G. AU - Griuncelli, M. AU - Loridon, C. AU - Couprie, R. AU - Benmaadi, A. AU - Bounhiol, C. PY - 2012 DA - 2012// TI - Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study JO - Am J Med VL - 125 UR - https://doi.org/10.1016/j.amjmed.2012.01.015 DO - 10.1016/j.amjmed.2012.01.015 ID - Rostoker2012 ER - TY - JOUR AU - Yamamoto, H. AU - Nishi, S. AU - Tomo, T. AU - Masakane, I. AU - Saito, K. AU - Nangaku, M. PY - 2017 DA - 2017// TI - 2015 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease JO - Renal Replace Ther VL - 3 UR - https://doi.org/10.1186/s41100-017-0114-y DO - 10.1186/s41100-017-0114-y ID - Yamamoto2017 ER - TY - JOUR AU - Kuragano, T. AU - Matsumura, O. AU - Matsuda, A. AU - Hara, T. AU - Kiyomoto, H. AU - Murata, T. PY - 2014 DA - 2014// TI - Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients JO - Kidney Int VL - 86 UR - https://doi.org/10.1038/ki.2014.114 DO - 10.1038/ki.2014.114 ID - Kuragano2014 ER - TY - JOUR AU - Bailie, G. R. AU - Larkina, M. AU - Goodkin, D. A. AU - Li, Y. AU - Pisoni, R. L. AU - Bieber, B. PY - 2015 DA - 2015// TI - Data from the Dialysis outcomes and practice patterns study validate an association between high intravenous iron doses and mortality JO - Kidney Int VL - 87 UR - https://doi.org/10.1038/ki.2014.275 DO - 10.1038/ki.2014.275 ID - Bailie2015 ER - TY - JOUR AU - Rostoker, G. AU - Griuncelli, M. AU - Loridon, C. AU - Magna, T. AU - Janklewicz, P. AU - Drahi, G. PY - 2014 DA - 2014// TI - Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0115096 DO - 10.1371/journal.pone.0115096 ID - Rostoker2014 ER - TY - JOUR AU - Wikström, B. AU - Bhandari, S. AU - Barany, P. AU - Kalra, P. A. AU - Ladefoged, S. AU - Wilske, J. PY - 2011 DA - 2011// TI - Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease JO - J Nephrol VL - 24 UR - https://doi.org/10.5301/JN.2011.6248 DO - 10.5301/JN.2011.6248 ID - Wikström2011 ER - TY - JOUR AU - Derman, R. AU - Roman, E. AU - Modiano, M. R. AU - Achebe, M. M. AU - Thomsen, L. L. AU - Auerbach, M. PY - 2017 DA - 2017// TI - A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia JO - Am J Hematol VL - 92 UR - https://doi.org/10.1002/ajh.24633 DO - 10.1002/ajh.24633 ID - Derman2017 ER - TY - JOUR AU - Agarwal, R. AU - Vasavada, N. AU - Sachs, N. G. AU - Chase, S. PY - 2004 DA - 2004// TI - Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease JO - Kidney Int VL - 65 UR - https://doi.org/10.1111/j.1523-1755.2004.00648.x DO - 10.1111/j.1523-1755.2004.00648.x ID - Agarwal2004 ER - TY - JOUR AU - Kuo, K. -. L. AU - Hung, S. -. C. AU - Lee, T. -. S. AU - Tarng, D. -. C. PY - 2014 DA - 2014// TI - Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD JO - J Am Soc Nephrol VL - 25 UR - https://doi.org/10.1681/ASN.2013080838 DO - 10.1681/ASN.2013080838 ID - Kuo2014 ER - TY - JOUR AU - Kuo, K. L. AU - Hung, S. -. C. AU - Lin, Y. -. P. AU - Tang, C. -. F. AU - Lee, T. -. S. AU - Lin, C. -. P. PY - 2012 DA - 2012// TI - Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0050295 DO - 10.1371/journal.pone.0050295 ID - Kuo2012 ER - TY - JOUR AU - Li, X. AU - Kshirsagar, A. V. AU - Brookhart, M. A. PY - 2017 DA - 2017// TI - Safety of intravenous iron in hemodialysis patients JO - Hemodial Int VL - 21 UR - https://doi.org/10.1111/hdi.12558 DO - 10.1111/hdi.12558 ID - Li2017 ER - TY - JOUR AU - Maynor, L. AU - Brophy, D. F. PY - 2007 DA - 2007// TI - Risk of infection with intravenous iron therapy JO - Ann Pharmacother VL - 41 UR - https://doi.org/10.1345/aph.1K187 DO - 10.1345/aph.1K187 ID - Maynor2007 ER - TY - JOUR AU - Fell, L. H. AU - Seiler-Mussler, S. AU - Sellier, A. B. AU - Rotter, B. AU - Winter, P. AU - Sester, M. PY - 2016 DA - 2016// TI - Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells JO - Nephrol Dial Transpl VL - 31 UR - https://doi.org/10.1093/ndt/gfw045 DO - 10.1093/ndt/gfw045 ID - Fell2016 ER -